The effects of Fosamax have been the subject of numerous studies published in medical journals since 2004. Although early studies failed to show a strong casual link between femur fractures and Fosamax use, lately an increasing number of individuals in the medical community have started to reject earlier sentiments and have begun to reexamine the effects of Fosamax. There is a growing consensus that previous studies did not monitor participants for a sufficient length of time and failed to provide the proper Fosamax dosage normally prescribed to women with osteoporosis.



Limitations on Earlier Studies



A wave of recent studies regarding the dangerous effects of Fosamax have linked the bisphosphonate to femur fractures. As these new facts about the dangerous effects of Fosamax emerge, researchers have been able to identify several control factors used in earlier studies that led to flawed findings regarding the effects of Fosamax. The defects identified in previous studies include failing to: review x-rays; recognize the fractures as atypical; observe the effects of Fosamax in women who took the drug for a prolonged period of time; and administer the Fosamax dosage normally prescribed to osteoporotic women. The recent studies, in which participants are treated with a Fosamax dosage of 10 mg daily or 70 mg weekly, have concluded that prolonged Fosamax does in fact increase the risk of sustaining a femur fracture. These new findings have forced regulatory agencies to revisit this issue. Prompted by new findings on the effects of Fosamax and other bisphosphonates, in October 2010, the U.S. Food and Drug Administration (FDA") required the manufacturers to change the drugs' labeling.



Fosamax Femur Fracture Lawsuit



If you or a loved one sustained a femur fracture as a result of Fosamax use, you may be able to file a lawsuit seeking compensation for your medical expenses, pain and suffering, lost wages and more. Contact one of our Fosamax lawyers today for a free and confidential evaluation. The lawyers at Bernstein Liebhard LLP have extensive litigation experience, and have recovered billions of dollars for their clients. In addition to being staunch advocates for your claim, our Fosamax injury lawyers also provide personal attention to guide you through the complex litigation process.
The defects identified in previous studies include failing to: review x-rays; recognize the fractures as atypical; observe the effects of Fosamax in women who took the drug for a prolonged period of time; and administer the Fosamax dosage normally prescribed to osteoporotic women. The recent studies, in which participants are treated with a Fosamax dosage of 10 mg daily or 70 mg weekly, have concluded that prolonged Fosamax does in fact increase the risk of sustaining a femur fracture. These new findings have forced regulatory agencies to revisit this issue. Prompted by new findings on the effects of Fosamax and other bisphosphonates, in October 2010, the U.S. Food and Drug Administration (FDA") required the manufacturers to change the drugs' labeling.

The defects identified in previous studies include failing to: review x-rays; recognize the fractures as atypical; observe the effects of Fosamax in women who took the drug for a prolonged period of time; and administer the Fosamax dosage normally prescribed to osteoporotic women. The recent studies, in which participants are treated with a Fosamax dosage of 10 mg daily or 70 mg weekly, have concluded that prolonged Fosamax does in fact increase the risk of sustaining a femur fracture. These new findings have forced regulatory agencies to revisit this issue. Prompted by new findings on the effects of Fosamax and other bisphosphonates, in October 2010, the U.S. Food and Drug Administration (FDA") required the manufacturers to change the drugs' labeling.